Fas-ligand expression on nucleus pulposus begins in developing embryo

Area of Science:

• Developmental Biology
• Immunology
• Histology

Background:

• The nucleus pulposus is an immune-privileged site, similar to the retina and testis.
• Immune privilege in other tissues is linked to Fas ligand expression, which induces apoptosis in T cells.
• Previous studies confirmed Fas ligand in mature rat and human nucleus pulposus, but its embryonic onset was unknown.

Purpose of the Study:

• To determine the developmental stage at which Fas ligand expression initiates in the embryonic nucleus pulposus.
• To understand the early molecular mechanisms underlying intervertebral disc immune privilege.

Main Methods:

• Immunohistochemical analysis of Fas ligand expression in rat embryo notochord and nucleus pulposus.
• Sequential examination of embryos at 14.5, 16.5, and 18.5 days of gestation.
• Observation via light microscopy.

Main Results:

• No Fas ligand expression was detected in the notochord of 14.5-day-old embryos.
• Weak Fas ligand staining appeared in some nucleus pulposus cells by 16.5 days of gestation.
• Intense Fas ligand staining was observed in most nucleus pulposus cells by 18.5 days of gestation.

Conclusions:

• Fas ligand expression emerges in the nucleus pulposus during intervertebral disc formation, not in the notochord.
• This suggests the immune privilege of the intervertebral disc may be established early in its development.
• Fas ligand likely plays a crucial role in both the formation and immune protection of the intervertebral disc.